Headquarters Laboratory 
97 Troy View Lane 24 Sherman Hall
Williamsville, NY 14221 3435 Main Street
Buffalo, NY 14214

A Company with a Mission

For-Robin, Inc., founded in 2012 is an antibody immunotherapy company whose primary mission is developing treatments for Breast Cancer (BrCa) patients. Our patented technology, monoclonal antibody, JAA-F11 and humanized variants, hJAA-F11, targets all BrCa cell subtypes including triple negative BrCa where no targeted therapy currently exists.

For-Robin, Inc is located in the Buffalo/Niagara region of upstate New York. The company has received designation as a StartUp New York company occupying R&D laboratory space at the University of Buffalo Main campus with access to university animal and shared resource facilities.

At For-Robin, Inc our mission to find treatments for Breast Cancer is personal. The company is named in honor of the founder's sister who died at age 31 of Breast Cancer. We feel now is the time to stop curing mice and embark on a mission to get this monoclonal antibody to clinical trials!

For-Robin is developing hJAA-F11 for adjunct therapy of BrCa either directly or as antibody-drug conjugates. Our strategic plan is to bring JAA-F11 to the clinical trial stage for breast cancer treatment with the intent to license our technology. Importantly, JAA-F11 should be applicable treatment for colon, prostate, lung, ovarian and bladder cancer patients. Our technology will have significant potential for broad future applications.

Media concerning For-Robin:

Website Builder